Electrospun Polycaprolactone/Collagen Scaffolds Enhance Manipulability and Influence the Composition of Self-Assembled Extracellular Matrix.
Farzamfar S., Chabaud S., Fradette J., Rioux Y., Bolduc S.
Laboratory Study, published in Bioengineering (Basel) (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Bioengineering (Basel) (2025)
- Country
- Switzerland
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41155075
- PMCID
- PMC12561681
- DOI
- 10.3390/bioengineering12101077
- Citations
- 1
Abstract (original English)
Cell-mediated extracellular matrix (ECM) self-assembly provides a biologically relevant approach for developing near-physiological tissue-engineered constructs by utilizing stromal cells to secrete and assemble ECM components in the presence of ascorbic acid. Despite its unique advantages, this method often results in scaffolds with limited mechanical properties, depending on the cell type. This research aimed to enhance the mechanical properties of these constructs by culturing cells derived from various sources, including skin, bladder, urethra, vagina, and adipose tissue, on electrospun scaffolds composed of polycaprolactone and collagen (PCLCOL). The hybrid scaffolds were evaluated using various in vitro assays to assess their structural and functional properties. Results showed that different stromal cells could deposit ECM on the PCLCOL with distinct composition compared to the ECM that was self-assembled on tissue culture plates (TCP). Additionally, cells cultured on PCLCOL exhibited a different growth factor secretion profile compared to those on TCP. Mechanical testing demonstrated that the hybrid scaffolds exhibited high mechanical properties and superior manipulability. These findings suggest that PCLCOL could be a promising platform for developing biomimetic scaffolds that combine enhanced mechanical strength with integrated biological cues for tissue repair.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.